Cypress Bioscience, Inc. (NASDAQ:CYPB.DL)
| CAPS Rating |
|
|---|
CYPB.DL
VS S&P 500 (SPY)
CYPB.DL News and Commentary
- Huge gain reaped by following activist investor – Blog at The Motley Fool
- Activist Investor Situation of the Day - Cypress Bioscience, Inc. (CYPB) – Blog at The Motley Fool
- Data for Bottom Fishers - June 21, 2010 – Blog at The Motley Fool
- Four Healthy Stocks Trading Above Moving Averages – Blog at The Motley Fool
- Five Healthcare Stocks Positioned for a Happy New Year – Blog at The Motley Fool
- Updated FDA Calendar: Buying Cypress Bio (CYPB) – Blog at The Motley Fool
- Trading the Trials: Cytori and Cypress Bio – Blog at The Motley Fool
- A Backlog of Decisions is Building at the FDA – Blog at The Motley Fool
- FDA Calendar: Likely Near-Term Movers – Blog at The Motley Fool
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
0
Outperform
0
Underperform
All-Star Players
0
Outperform
0
Underperform
Wall Street
0
Outperform
0
Underperform
RSS Headlines
Fool UK
